ASH News Daily 2017 - Issue 2 - B-10

ASH News Daily

Page B-10

Sunday, December 10, 2017

FocuS on traineeS

2017 Trainee Activities: Same Dedication to
Excellence, With a Few New Twists

s you read in yesterday's ASH News Daily, the ASH annual
meeting provides hematology trainees with a variety of highquality educational, career-development, and networking opportunities. To help trainees make the most of their meeting experience, a number of activities and services have been identified as most
relevant to the unique interests of undergraduates, medical and graduate students, residents, and fellows (MD and PhD).

Trainee Lounge Hours
Sunday, December 10
7:00 a.m. - 5:00 p.m.
Monday, December 11
7:00 a.m. - 5:00 p.m.
Tuesday, December 12
7:00 a.m. - 1:30 p.m.
Trainee Simultaneous
Didactic Sessions:
During lunch on Sunday and
Monday, ASH will offer didactic ses-

ASH

B
EM

EF
N
E
B

sions designed to provide trainees
with an overview of timely and relevant career-oriented issues. Lunch
will be provided. Space is available
on a first-come, first-served basis.
As seating is limited, attendees are
strongly encouraged to arrive early.
No additional participants will be
allowed in the rooms once these
sessions are filled. See tomorrow's
ASH News Daily for information on
Monday's didactic sessions.

Today, December 10, 2017,
11:15 a.m. - 12:15 p.m.
Time Management and Balance
Georgia World Congress Center,
Building B, Level 2, Rooms B211-B212
This session will focus on the importance of time management and
balance from both the clinical and lab
perspectives. The expert panel will
discuss time management challenges
and successful strategies for dealing
with issues. Using examples, they
will also discuss various models for
achieving work-life balance.
Speakers:
Time Management and Balance
in the Pediatric/Laboratory Setting:
Sara E Meyer, PhD
Thomas Jefferson University,
Sidney Kimmel Cancer Center
Philadelphia, PA

Time Management and Balance
in the Adult/Clinical Setting:
Jean L. Koff, MD
Winship Cancer Institute of Emory University
Atlanta, GA
Drug Development
Georgia World Congress Center,
Building B, Level 2, B207-B208
This session will focus on drug development for targeted therapy and
immunotherapy. The speaker will
describe the steps in the regulatory
process for investigational new drug
applications with a focus on drug
testing, early phase clinical trials, and
newer adaptive trials designs.
Speaker:
Michael R. Grever, MD
The Ohio State University Hospital
Columbus, OH

Get advice on difficult cases from specialists in the field.

Consult a Colleague
The Consult-a-Colleague program is an ASH member benefit that
facilitates the exchange of information and treatment strategies between
ASH members and volunteer specialists in the following categories:
l

Anemias
Hemoglobinopathies
Hematopoietic Cell Transplantation
Hemostasis/Thrombosis
Leukemias
Lymphomas

Lymphoproliferative Disorders
Multiple Myeloma & Waldenström
Macroglobulinemia
Myeloproliferative Disorders
Myelodysplastic Syndromes
Thrombocytopenias

Submit a request at www.hematology.org/consult
and receive a response within two business days.

http://www.hematology.org/consult

Table of Contents for the Digital Edition of ASH News Daily 2017 - Issue 2